One-Carbon Therapeutics

One-Carbon Therapeutics

One-Carbon Therapeutics AB is tackling the most difficult to treat cancers, inflammation and autoimmune diseases by targeting the disease specific one-carbon metabolism pathway, representing a novel way of attacking the DNA damage response (DDR).

They take advantage of their deep biological understanding of metabolism and DNA repair processes to develop novel therapeutic approaches targeting both.

One-Carbon Therapeutics joined NOME in 2023.